Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Sunshine Biopharma (SBFM) over the last 16 years, with Dec 2024 value amounting to -$14.2 million.

  • Sunshine Biopharma's Free Cash Flow rose 60.73% to -$735,840 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year increase of 42.96%. This contributed to the annual value of -$14.2 million for FY2024, which is 60.19% down from last year.
  • Per Sunshine Biopharma's latest filing, its Free Cash Flow stood at -$14.2 million for FY2024, which was down 60.19% from -$8.9 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Free Cash Flow peaked at -$658,490 during FY2020, and registered a low of -$14.2 million during FY2024.
  • Over the past 3 years, Sunshine Biopharma's median Free Cash Flow value was -$8.9 million (recorded in 2023), while the average stood at -$9.5 million.
  • Data for Sunshine Biopharma's Free Cash Flow shows a maximum YoY slumped of 197.54% (in 2022) over the last 5 years.
  • Sunshine Biopharma's Free Cash Flow (Yearly) stood at -$658,490 in 2020, then plummeted by 177.78% to -$1.8 million in 2021, then plummeted by 197.54% to -$5.4 million in 2022, then tumbled by 62.75% to -$8.9 million in 2023, then tumbled by 60.19% to -$14.2 million in 2024.